E-scooter company Neuron is set to face a new safety trial following an influx of injuries to both riders and pedestrians in Brisbane this year.
The trial will test the efficiency of three new technologies, including high accuracy location technology (HALT), rapid geofence detection, and dangerous riding detection, allowing the parent company to track scooters through sensors and implement restrictions if dangerous activity is detected. From there, the app can send riders warnings and information packages about their behaviour, and even ban repeat offenders.
Head of Neuron New Zealand Richard Hannah emphasised the company’s focus on safety, and said they are excited to bring new technologies to Brisbane, which he described as a landmark city for the company.